By upregulating BCAAs transaminases (such as BCAT1 and BCAT2) (Günther et al., 2022; Hutson et al., 1998; Ma et al., 2022),cancer cells enhance their metabolic activity, promoting growth and reducing sensitivity to chemotherapy drugs. Here, BCAT2 is linked to cancer.